Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > -20%...

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Aug 15, 2022 11:03am

227 Views

Post# 34896486

-20%...

...of MC wiped out in the past week or so, or about $ 30M...so far...

...wiped out by some "horrible" news like ....

continued "exceeding expectations" on Tigris
ARC SAMI sale
Break Through Designation for PMX (=FDA commitments for more rapid turn-around, and likely enhanced probablitly of ultimate approval).
US Dept. of VA acceptance of SAMI
Baxter pre-marketing activity on PMX
Close to full partnership enrollment, DIMI Trial

or maybe it's in anticipation of....